Study Confirms How Common Natural Herbal Remedies Treat High Blood Pressure from Natural Blaze
GNN Note – The scientific world can no longer hide truths about herbal remedies and essential oils being the wonder drugs they have been for thousands of years. Cancer is a new phenomenon and cancer is here because we no longer use turmeric, garlic, lavender and all the other roots, leaves and flowers that God gave us to heal our bodies. Pills made in a factory are devoid of a soul, plants of the the Non-GMO persuasion, come directly from God – let that sink in for just a minute.
Common herbs, including lavender, fennel and chamomile, have a long history of use as folk medicines used to lower blood pressure. In a new study, University of California, Irvine researchers explain the molecular mechanisms that make them work.
Published today in Proceedings of the National Academy of Sciences (PNAS), the study illustrates how many of the known traditional botanical plants used to lower blood pressure activate a specific potassium channel (KCNQ5) in blood vessels.
KCNQ5, together with other potassium channels including KCNQ1 and KCNQ4, is expressed in vascular smooth muscle. When activated, KCNQ5 relaxes blood vessels, making it a logical mechanism for at least part of the hypotensive actions of certain botanical folk medicines.
Lavender, fennel and chamomile among herbs discovered to act upon a shared therapeutic target in blood vessels
“We found KCNQ5 activation to be a unifying molecular mechanism shared by a diverse range of botanical hypotensive folk medicines. Lavandula angustifolia, commonly called lavender, was among those we studied. We discovered it to be among the most efficacious KCNQ5 potassium channel activators, along with fennel seed extract and chamomile,” said Geoff Abbott, PhD, professor of physiology and biophysics at the UCI School of Medicine and senior investigator on the study.
Interestingly, the KCNQ5-selective potassium channel activation feature found in the botanicals is lacking in the modern synthetic pharmacopeia. Until now, it seems to have eluded conventional screening methods utilizing chemical libraries, which may account for why it is not a recognized feature of synthetic blood pressure medications.
“Our discovery of these botanical KCNQ5-selective potassium channel openers may enable development of future targeted therapies for diseases including hypertension and KCNQ5 loss-of-function encephalopathy,” said Abbott.